NEEDHAM, Mass. (AP) — NEEDHAM, Mass. (AP) — Verastem Inc. (VSTM) on Thursday reported a loss of $25.9 million in its second quarter.
On a per-share basis, the Needham, Massachusetts-based company said it had a loss of 39 cents.
The drug developer posted revenue of $2.1 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $15.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VSTM at https://www.zacks.com/ap/VSTM
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
